Clinical trials sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.

Phase breakdown

Conditions studied

Recruiting trials led by Otsuka Pharmaceutical Development & Commercialization, Inc.

• A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07759128 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
  NCT06894212 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 73 locations
• A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07767903 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many trials is Otsuka Pharmaceutical Development & Commercialization, Inc. recruiting for?

Otsuka Pharmaceutical Development & Commercialization, Inc. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.